Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-021510

Director acquired 1,048,951 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

George Simeon · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-27 Grant or award : show line 1 in the form +63,177 $71.50 $4,517,156 63,177 I
2024-02-27 Grant or award : show line 2 in the form +216,578 $71.50 $15,485,327 216,578 I
2024-02-27 Grant or award : show line 3 in the form +769,196 $71.50 $54,997,514 769,196 I
Loading xslF345X05/ownership.xml…